
Mercy Infusion supports patients prescribed Xembify through coordinated SCIG Therapy services designed to simplify ongoing treatment and improve the patient experience.
Our team assists with Home Infusion onboarding, insurance coordination, therapy education, refill coordination, and ongoing support throughout treatment.
Xembify is a subcutaneous immune globulin therapy commonly prescribed for patients requiring ongoing immunoglobulin replacement therapy.
Mercy Infusion supports patients prescribed Xembify through coordinated SCIG Therapy and Home Infusion services designed to support long-term therapy management.
Xembify may be prescribed for patients managing:
Xembify is commonly coordinated through Mercy Infusion’s Home Infusion program, allowing eligible patients to receive ongoing SCIG therapy in the comfort of home.
Our team helps support:
Clinical coordination through our Infusion Suite may also be utilized depending on physician direction and patient needs.
Mercy Infusion helps simplify long-term SCIG therapy management by assisting with:
Our team works closely with physicians, patients, and insurance providers to help support uninterrupted therapy access.
Is Xembify administered through Home Infusion?
Yes. Xembify is commonly coordinated through Mercy Infusion’s Home Infusion program depending on physician direction.
Can Mercy Infusion help coordinate insurance approvals?
Yes. Our team assists with benefits verification, prior authorization coordination, and therapy onboarding support.
If you’ve been prescribed Xembify and are exploring Home Infusion options, Mercy Infusion is here to help.